Cerebrospinal fluid and serum MHPG improve Alzheimer's disease versus dementia with Lewy bodies differential diagnosis

@inproceedings{Janssens2018CerebrospinalFA,
  title={Cerebrospinal fluid and serum MHPG improve Alzheimer's disease versus dementia with Lewy bodies differential diagnosis},
  author={Jana Janssens and Yannick Vermeiren and Erik Frans{\'e}n and T. M. Aerts and Debby Van Dam and Sebastiaan Engelborghs and Peter Paul De Deyn},
  booktitle={Alzheimer's & dementia},
  year={2018}
}
Introduction Given the challenges concerning the differential diagnosis of dementia, we investigated the possible added value of monoaminergic compounds to the standard cerebrospinal fluid (CSF) Alzheimer's disease (AD) biomarkers. Particularly, regarding the AD versus dementia with Lewy bodies (DLB) comparison, monoamines or their metabolites might have… CONTINUE READING